sniff results
“Oncology”
389 total hits · 4 drugs · 36 companies · 0 diseases · 292 catalysts · 57 news
Drugs(4)
expand →
Preclinical
Drugs for Oncology
Pancreatic Ductal Adenocarcinoma
Phase 1Gene Therapy to Target CD22 for Oncology
B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia)
PreclinicalImmuno-oncology
Breast Cancer
Phase 1Peptide to Inhibit CD200 for Oncology
Recurrent Glioblastoma Multiforme (GBM)
🐶 Companies(36)
expand →
Catalysts(292)
expand →
News(57)
expand →
- GSK pens $1.3B Hutchmed deal for early-stage KRAS-EGFR cancer assetGSK is handing over $110 million upfront to Hutchmed in a deal worth up to $1.295 billion to get its hands on a first-in-class oncology candidate.fiercebiotech · 3d ago
- Roche finds another oncology gem in Asia with $1.5B B cell disease partnershipRoche has tapped Simcere Zaiming for a new T cell engager that could have broad application in B cell–mediated diseases including lymphoma and autoimmune conditions.biospace · 5d ago
- Roche inks $1.53B deal for Simcere’s B-cell-targeting antibodyRoche is paying oncology-focused Simcere Zaiming $75 million upfront for global rights to a preclinical trispecific antibody targeting B-cell-mediated diseases.fiercebiotech · 5d ago